Toxicological and clinical data for the tolerability and safety of Ginkgo biloba leaf extract
Received Date: May 02, 2022 / Published Date: May 25, 2022
Abstract
Ginkgo biloba is one of the most widely used herbal remedies in Europe and the US. It may be purchased in different types of formulations, but most of the clinical studies have been performed with the controlled G. biloba extract. Indications include Alzheimers disease, cardiovascular disease, dementia, memory loss, and cerebral ischemia. The pharmacological modes of action cover antioxidant effects, radical scavenging, inhibition of platelet activating factor, alterations in membrane fluidity (signal transduction), and inhibition of glucocorticoid synthesis. Due to the widespread and long-term use of G. biloba – about a million doses of EGb761® are sold per day – tolerability and safety are a crucial issue. Based on broad and long-term clinical use of G. biloba extracts, it is regarded as well tolerated in man.
Citation: Lyion S (2022) Toxicological and clinical data for the tolerability and safety of Ginkgo biloba leaf extract. Toxicol 天美传媒 Access 8: 178. Doi: 10.4172/2476-2067.1000178.
Copyright: © 2022 Lyion S. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
天美传媒 Access Journals
Article Tools
Article Usage
- Total views: 1396
- [From(publication date): 0-2022 - Jan 10, 2025]
- Breakdown by view type
- HTML page views: 1060
- PDF downloads: 336
